Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes

International Journal of Pharmaceutics

Volumn 183, Issue 2, 1999, Pages 195-207

  Birchall, James C ^a   Kellaway, Ian W ^a   Mills, Simon N ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cationic liposome; DNA; Gene therapy; Physico chemical characterisation; Transfection

Indexed keywords

LIPOSOME; PLASMID DNA;

ANIMAL CELL; ARTICLE; CLONING VECTOR; DRUG FORMULATION; ELECTRON MICROSCOPY; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MONKEY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; ELECTROPHORESIS; ELECTROPHORESIS, AGAR GEL; ELECTROSTATICS; FATTY ACIDS, MONOUNSATURATED; FIBROBLASTS; FLUORESCENT DYES; HAPLORHINI; HUMANS; KIDNEY; LIPIDS; LIPOSOMES; LUNG NEOPLASMS; MICROSCOPY, ELECTRON; PARTICLE SIZE; PLASMIDS; QUATERNARY AMMONIUM COMPOUNDS; SPECTROPHOTOMETRY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033066932     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00117-9     Document Type: Article

References (37)

1. Brigham K.L., Schreier H. Cationic liposomes and DNA delivery. J. Liposome Res. 3:1993;31-49.
2. Crook K., McLachlan G., Stevenson B.J., Porteus D.J. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. 3:1996;834-839.
3. Duncan J.E., Whitsett J.A., Horowitz A.D. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Human Gene Ther. 8:1997;431-438.
4. Farhood H., Serbina N., Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta. 1235:1995;289-295.
5. Fasbensder A., Marshall J., Moninger T.O., Grunst T., Cheng S., Welsh M.J. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. 4:1997;716-725.
6. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7413-7417.
7. Felgner P.L., Tsai Y.J., Sukhu L., Wheeler C.J., Manthorpe M., Marshall J., Cheng S.H. Improved cationic lipid formulations for in vivo gene therapy. Ann. N.Y. Acad. Sci. 772:1995;126-139.
8. Gao X., Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2:1995;710-722.
9. Gershon H., Ghirlando R., Guttman S.B., Minsky A. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry. 32:1993;7143-7151.
10. Gustafsson J., Arvidson G., Karlsson G., Almgren M. Complexes formed between cationic liposomes and DNA visualized by cryo-TEM. Biochim. Biophys. Acta. 1235:1995;305-312.
11. Koltover I., Salditt T., Rädler J.O., Safinya C.R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science. 281:1998;78-81.
12. Kruger N.J. The Bradford method for protein quantitation. Walker J.M. Methods in Molecular Biology. Volume 32: Basic Protein and Peptide Protocols:1991;The Humana Press, Totowa, NJ.
13. Lasic D.D., Templeton N.S. Liposomes in gene therapy. Adv. Drug Delivery Rev. 20:1996;221-266.
14. Lee R.J., Huang L. Lipidic systems for gene transfer. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;173-206.
15. Li S., Gao X., Son K., Sorgi F., Hofland H., Huang L. DC-Chol lipid system in gene transfer. J. Control. Release. 39:1996;373-381.
16. Litzinger D.C., Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta. 1113:1992;201-227.
17. MacGregor G.R., Nolan G.P., Fiering S., Roederer M., Herzenberg L.A. Use of E. coli lacZ (β-galactosidase) as a reporter gene. Murray E.J. Methods in Molecular Biology. Volume 7: Gene Transfer and Expression Protocols, 1991;The Humana Press, Clifton, NJ.
18. Mahato R.I., Kawabata K., Takakura Y., Hashida M. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J. Drug Targeting. 3:1995;149-157.
19. Mahato R.I., Kawabata K., Nomura T., Takakura Y., Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84:1995;1267-1271.
20. Mahato R.I., Takakura Y., Hashida J.E. Development of targeted delivery systems for nucleic acid drugs. J. Drug Targeting. 4:1997;337-357.
21. McLachlan G., Davidson D.J., Stevenson B.J., Dickinson P., Davidson-Smith H., Dorin J.R., Porteus D.J. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther. 2:1995;614-622.
22. McLachlan G., Ho L.-P., Davidson-Smith H., Samways J., Davidson H., Stevenson B.J., Carothers A.D., Alton E.W.F.W., Middleton P.G., Smith S.N., Kallmeyer G., Michaelis U., Seeber S., Naujoks K., Greening A.P., Innes J.A., Dorin J.R., Porteus D.J. Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene Ther. 3:1996;1113-1123.
23. New R.R.C. Liposomes: A Practical Approach. 1990;Oxford University Press, Oxford, UK.
24. Philip R., Liggitt D., Philip M., Dazin P., Debs R. In vivo gene delivery. J. Biol. Chem. 268:1993;16087-16090.
25. Reimer D.L., Zhang Y.-P., Kong S., Wheeler J.J., Graham R.W., Bally M. Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. Biochemistry. 34:1995;12877-12883.
26. Rolland A.P. From genes to gene medicines: recent advances in nonviral gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;143-198.
27. Rose J.K., Buonocore L., Whitt M.A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques. 10:1991;520-525.
28. Ruysschaert J.-M., El Ouahbi A., Willeaume V., Huez G., Fuks R., Vandenbranden M., Di Stefano P. A novel cationic amphiphile for transfection of mammalian cells. Biochem. Biophys. Res. Commun. 203:1994;1622-1628.
29. Smith B.T. Cell line A549: a model system for the study of alveolar type II cell function. Am. Rev. Resp. Dis. 115:1977;285-293.
30. Sternberg B., Sorgi F.L., Huang L. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356:1994;361-366.
31. Sternberg B., Sorgi F.L., Huang L. Complex formation between DNA and cationic liposomes visualized by freeze fracture electron microscopy. J. Mol. Med. 73:1995;4.
32. Tomlinson E., Rolland A.P. Controllable gene therapy: pharmaceutics of non-viral gene delivery systems. J. Control. Release. 39:1996;357-372.
33. Tsan M.-F., Tsan G.L., White J.E. Surfactant inhibits cationic liposome-mediated gene transfer. Hum. Gene Ther. 8:1997;817-825.
34. Yang J.-P., Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4:1997;950-960.
35. Zabner J. Cationic lipids used in gene transfer. Adv. Drug Delivery Rev. 27:1997;17-28.
36. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:1995;18997-19007.
37. Zelphati O., Szoka F.C. Jr. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? J. Control. Release. 41:1996;99-119.